Ph.D. in Immunology, Stanford University School of Medicine, 2012
Post-doctoral Fellow, National Institute of Child Health and Human Development, National Institutes of Health
Palin, A. C., Ramachandran, V., Acharya, S. and Lewis, D. B. (2013). Human neonatal naive CD4+ T cells have enhanced activation-dependent signaling regulated by the microRNA miR-181a. J Immunol 190(6): 2682-2691.
Wilson, S. R., Wilson, J. H., Buonocore, L., Palin, A., Rose, J. K. and Reuter, J. D. (2008). Intranasal immunization with recombinant vesicular stomatitis virus expressing murine cytomegalovirus glycoprotein B induces humoral and cellular immunity. Comp Med 58(2): 129-139.
Palin, A., Chattopadhyay, A., Park, S., Delmas, G., Suresh, R., Senina, S., Perlin, D. S. and Rose, J. K. (2007). An optimized vaccine vector based on recombinant vesicular stomatitis virus gives high-level, long-term protection against Yersinia pestis challenge. Vaccine 25(4): 741-750.
Ramsburg, E., Publicover, J., Buonocore, L., Poholek, A., Robek, M., Palin, A. and Rose, J. K. (2005). A vesicular stomatitis virus recombinant expressing granulocyte-macrophage colony-stimulating factor induces enhanced T-cell responses and is highly attenuated for replication in animals. J Virol 79(24): 15043-15053.
Protocols by Amy Palin
Transfection of Human Naive CD4+ T Cells with PHA Activation and Neon Electroporation